Sobi is extending its reach in international markets including Russia and China and expects its late-stage R&D pipeline to drive growth.

Latest Oncology Center of Excellence initiative is officially a CME effort designed to encourage practitioners to make full use of the information in the approved drug labeling. It is also a surprisingly effective way to explain drug approvals in a flattering light for regulators and sponsors.

In tandem with buying the rest of Kleo, Tonix licenses molecular degradation technology from Yale. Neurogene, University of Dundee partner on cell therapies for neurological disorders.

Gilead and Roche ended the year involved in three novel agents apiece, thanks to a combination of internal research and external licensing.